The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
Published Online:https://doi.org/10.1176/ajp.96.4.951

The rate of detoxication of benzoic acid was determined in patients with various neuropsychiatric diseases. About one half of the patients with catatonia showed a defect in hippuric acid synthesis. This may be due to the state of muscular rigidity and immobility of these patients. Deteriorated patients with epilepsy showed a defect in the synthesis of hippuric acid, whereas extramural patients with epilepsy showed a normal excretion of the equivalent benzoic acid. This may indicate a defect in glycine synthesis in deteriorated patients with epilepsy. Normal average values were found in post-encephalitic Parkinsonism and multiple sclerosis. A patient with progressive muscular dystrophy was able to synthesize glycine at a normal rate.

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.